Form 4: Centessa Pharmaceuticals Executive Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
David M. Chao, Chief Administrative Officer of Centessa Pharmaceuticals plc, disposed of 10,385 ordinary shares to cover tax withholding obligations related to vesting restricted share units.
Summary
- David M. Chao, Chief Administrative Officer of Centessa Pharmaceuticals plc, filed a Form 4 with the SEC on April 2, 2024.
- The form reports a transaction that occurred on March 31, 2024, where 10,385 ordinary shares were disposed of at a price of $11.3 per share.
- This disposal was to cover tax withholding obligations in connection with the vesting of restricted share units.
- Following the transaction, Chao directly owns 272,986 ordinary shares of Centessa Pharmaceuticals plc.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't indicate any fundamental change in the company's prospects or insider sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard process of covering tax obligations related to equity compensation.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of transaction: Disposal of 10,385 ordinary shares. |
| 04/02/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.